Evidence map›Paper›PMID 34633288›Full record

ArticleeLife2021

Protein phosphatase 1 in association with Bud14 inhibits mitotic exit in

Dilara Kocakaplan, Hüseyin Karabürk, Cansu Dilege, Idil Kirdök, Seyma Nur Bektas, Ayse Koca Caydasi

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. The signalling lipid PI3,5POpen biology · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dilara Kocakaplan *Department of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Hüseyin Karabürk *Department of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Cansu DilegeDepartment of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Idil KirdökDepartment of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Seyma Nur BektasDepartment of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Ayse Koca CaydasiDepartment of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.ORCID 0000-0003-2570-1367
Koç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitotic exit in budding yeast is dependent on correct orientation of the mitotic spindle along the cell polarity axis. When accurate positioning of the spindle fails, a surveillance mechanism named the spindle position checkpoint (SPOC) prevents cells from exiting mitosis. Mutants with a defective SPOC become multinucleated and lose their genomic integrity. Yet, a comprehensive understanding of the SPOC mechanism is missing. In this study, we identified the type 1 protein phosphatase, Glc7, in association with its regulatory protein Bud14 as a novel checkpoint component. We further showed that Glc7-Bud14 promotes dephosphorylation of the SPOC effector protein Bfa1. Our results suggest a model in which two mechanisms act in parallel for a robust checkpoint response: first, the SPOC kinase Kin4 isolates Bfa1 away from the inhibitory kinase Cdc5, and second, Glc7-Bud14 dephosphorylates Bfa1 to fully activate the checkpoint effector.

Indexed as

Cell PolarityMitosisM Phase Cell Cycle CheckpointsProtein Phosphatase 1Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSpindle ApparatusBud14 protein, S cerevisiaeGLC7 protein, S cerevisiaeProtein Phosphatase 1Saccharomyces cerevisiae Proteinscell biologycell cyclemitotic exitPP1S. cerevisiaesignallingspindle position checkpoint

Identifiers

PMID34633288
PMCPMC8577847
OpenAlexW3205508582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.